Education

1996-1998  Peking Union Medical College  MD

1990-1996  Shandong Medical University

   

Academic Experience

2020.12-present  Professor    Changping laboratory

2018.4 -present   Professor    Tsinghua University-Peking University Joint Center for Life Sciences

2015.07-present  Attending Physician  China-Japan Friendship Hospital

2009.9-present    Professor    Beijing Chaoyang Hospital, Capital Medical University
2006.10-2009.8   Associate Professor    Beijing Chaoyang Hospital, Capital Medical University
2003.3-2006.9     Attending Physician    Peking Union Medical College Hospital
2002.7-2003.2     Chief Resident    Peking Union Medical College Hospital
1998.8-2002.6     Resident    Peking Union Medical College Hospital
   

Overview of Academic Research

Prof. Bin Cao and his team have been dedicated to answering key questions in the field of respiratory infection and emerging infectious diseases. His major research field is immune response in viral pneumonia and respiratory viral sepsis. He has conducted innovative work in the epidemiology, microbiology, immuno-pathogenesis, and clinical treatment in infection of influenza virus, adenovirus, mycoplasma, and drug-resistant bacteria. His work has been cited in many clinical guidelines and he has published 9 articles in NEJM and Lancet.

His research interest include:

1.        Epidemiology and clinical characteristics of viral pneumonia;

2.        Pathogenesis and molecular mechanism of viral sepsis;

3.        Diagnosis and treatment strategy and drug resistance of drug-resistant pathogens.

Major Honor and Awards

2021 Huaxia Medical Science and Technology Award

2020 Shanghai Science and Technology Award (First Prize)

2020 Advanced Individual in the National Fight against COVID-19

2020 National Innovation Competition Award

2018 Outstanding Respiratory Academic Contribution Award

2017 National Award for Science and Technology Progress (Grand Prize)

2016 Science and Technology Award of Chinese Preventive Medicine Association (First Prize)

2014 Wu JiePing-Paul Janssen Medical-Pharmaceutical Award    

2011 Beijing Science and Technology Award (First Prize)

Representative Research Achievements

1.Lixue Huang, Xia Li, Xiaoying Gu , Hui Zhang, LiLi Ren, Li Guo, Min Liu, Yimin Wang, Dan Cui, Yeming Wang, Xueyang Zhang, Lianhan Shang, Jingchuan Zhong, Xinming Wang, Jianwei Wang* , Bin Cao*.Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022 May 11; S2213-2600(22)00126-6.

2.Lixue Huang, Qun Yao, Xiaoying Gu, Qiongya Wang, Lili Ren, Yeming Wang, Ping Hu, Li Guo, Min Liu, Jiuyang Xu, Xueyang Zhang, Yali Qu, Yanqing Fan, Xia Li, Caihong Li, Ting Yu, Jiaan Xia, Ming Wei, Li Chen, Yanping Li, Fan Xiao, Dan Liu, Jianwei Wang*, Xianguang Wang*, Bin Cao*. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet, 398(10302), 747-758 (2021)

3.Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu, Zhenshun Cheng, Ting Yu, Jiaan Xia, Yuan Wei, Wenjuan Wu, Xuelei Xie, Wen Yin, Hui Li, Min Liu, Yan Xiao, Hong Gao, Li Guo, Jungang Xie, Guangfa Wang, Rongmeng Jiang, Zhancheng Gao, Qi Jin, Jianwei Wang*, Bin Cao*. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 395(10223): 497-506

4.Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, Jie Xiang, Yeming Wang, Bin Song, Xiaoying Gu, Lulu Guan, Yuan Wei, Hui Li, Xudong Wu, Jiuyang Xu, Shengjin Tu, Yi Zhang, Hua Chen*, Bin Cao*. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020, 395(10229): 1054-1062

5.Hui Li, Liang Liu, Dingyu Zhang, Jiuyang Xu, Huaping Dai, Nan Tang, Xiao Su, Bin Cao. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet, 2020, 395(10235): 1517-1520

6. Bin Cao*, Yeming Wang, Danning Wen, Wen Liu, Jingli Wang, Guohui Fan, Lianguo Ruan, Bin Song, Yanping Cai, Ming Wei, Xingwang Li, Jiaan Xia, Nanshan Chen, Jie Xiang, Ting Yu, Tao Bai, Xuelei Xie, Li Zhan, Caihong Li, Ye Yuan, Hua Chen, Huadong Li, Hanping Huang, Shengjing Tu, Fengyun Gong, Ying Liu, Yuan Wei, Chongya Dong, Fei Zhou, Xiaoying Gu, Jiuyang Xu, Zhibo Liu, Yi Zhang, Hui Li, Lianhan Shang, Ke Wang, Kunxia Li, Xia Zhou, Xuan Dong, Zhaohui Qu, Sixia Lu, Xujuan Hu, Shunan Ruan, Shanshan Luo, Jing Wu, Lu Peng, Fang Cheng, Lihong Pan, Jun Zou, Chunmin Jia, Juan Wang, Xia Liu, Shuzhen Wang, Xudong Wu, Qin Ge, Jing He, Haiyan Zhan, Fang Qiu, Li Guo, Chaolin Huang, Thomas Jaki, Frederick G Hayden, Peter W Horby, Dingyu Zhang*, Chen Wang*. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med, 2020, 382(19): 1787-1799

7.eming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, Shouzhi, Ling Gao, Zhenshun Cheng, Qiaofa Lu, Yi Hu, Guangwei Luo, Ke Wang, Yang Lu, Huadong Li, Shuzhen Wang, Shunan Ruan, Chengqing Yang, Chunlin Mei, Yi Wang, Dan Ding, Feng Wu, Xin Tang, Xianzhi Ye, Yingchun Ye, Bing Liu, Jie Yang, Wen Yin, Aili Wang, Guohui Fan, Fei Zhou, Zhibo Liu, Xiaoying Gu, Jiuyang Xu, Lianhan Shang, Yi Zhang, Lianjun Cao, Tingting Guo, Yan Wan, Hong Qin, Yushen Jiang, Thomas Jaki, Frederick G Hayden, Peter W Horby, Bin Cao*, Chen Wang*. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet, 2020, 395(10236): 1569-1578

8.Xuehong Jia, Bo Liu, Linlin Bao, Qi Lv, Fengdi Li, Hui Li, Yunqing An, Xulong Zhang*, Bin Cao*, Chen Wang*. Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration. PLoS Pathog, 2018, 14(11): e1007428

9.Hui Li, Konrad C Bradley, Jason S Long, Rebecca Frise, Jonathan W Ashcroft, Lorian C Hartgroves, Holly Shelton, Spyridon Makris, Cecilia Johansson, Bin Cao*, Wendy S Barclay*. Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice. PLoS Pathog, 2018, 14(1): e1006821

10.Bin Cao,* Xing-Wang Li*, Yu Mao*, Jian Wang*, Hong-Zhou Lu*, Yu-Sheng Chen*, Zong-An Liang*, Lirong Liang, Su-Juan Zhang, Bin Zhang, Li Gu, Lian-He Lu, Da-Yan Wang, Chen Wang; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med, 2009, 361(26): 2507-2517